Orchestra BioMed Holdings, Inc. Ordinary Shares
OBIO •
Sell Closed
Signal type
Sell
Status
Closed
Open Price
$4.04
Closed Price
$4.51
Performance
-11.63%
Days Open
15
Signal Setup
Signal Type Sell
Status Closed
Open Date Mar 30, 2026
Open Price $4.04
Stop Loss $5.00
Timespan Day
Trade Outcome
Closed Status Loss
Closed Date Apr 14, 2026
Closed Price $4.51
Performance -11.63%
Days Open 15
Company Profile
Name Orchestra BioMed Holdings, Inc. Ordinary Shares
Ticker OBIO
Market Cap $102.68M
Sector SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Latest Close $4.51
List Date Jan 27, 2023
Description
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
Website Open Company Website